Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI
Author:
Publisher
Elsevier BV
Subject
Transplantation,Hematology
Reference47 articles.
1. A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma;Shimoni;Cancer,2012
2. The evolving role of stem cell transplants in lymphomas;Jantunen;Biol Blood Marrow Transplant,2012
3. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry;Freytes;Blood,2004
4. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect;van Besien;Bone Marrow Transplant,1997
5. Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma;Castagna;Biol Blood Marrow Transplant,2009
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient’s perspective?;Supportive Care in Cancer;2020-10-17
2. Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results;Biology of Blood and Marrow Transplantation;2019-07
3. High-dose Preparatory Regimens;Thomas’ Hematopoietic Cell Transplantation;2016-01-01
4. Forty years of haematopoietic stem cell transplantation: a review of the Basel experience;Swiss Medical Weekly;2014-02-24
5. Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial;Bone Marrow Transplantation;2013-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3